Grant Private Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.54M Buy
2,194
+933
+74% +$1.1M 1.14% 16
2026
Q2
$1.51M Buy
1,261
+85
+7% +$86.8K 0.64% 31
2026
Q1
$1.08M Buy
1,176
+238
+25% +$241K 0.57% 39
2025
Q4
$1.01M Sell
938
-16
-2% -$15.3K 0.61% 36
2025
Q3
$728K Buy
954
+518
+119% +$385K 0.45% 44
2025
Q2
$340K Sell
436
-423
-49% -$329K 0.19% 51
2025
Q1
$709K Buy
859
+469
+120% +$390K 0.77% 36
2024
Q4
$301K Buy
+390
New +$323K 0.32% 84

Other funds holding LLY

Grant Private Wealth Management's LLY Position: Q3 2026 in Review

Grant Private Wealth Management increased its Eli Lilly (LLY) stake by 74% in Q3 2026, buying an estimated $1.1M and bringing the position to 2,194 shares worth $2.54M. The position accounts for 1.14% of the portfolio, ranked #16.

Grant Private Wealth Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Grant Private Wealth Management held 2,194 shares of Eli Lilly worth $2.54M as of Q3 2026.
  • Grant Private Wealth Management bought 933 Eli Lilly shares in Q3 2026, an estimated $1.1M.
  • Eli Lilly made up 1.14% of Grant Private Wealth Management's portfolio in Q3 2026, its #16 holding.
  • Grant Private Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Grant Private Wealth Management's 13F filing for Q3 2026, filed 19 Oct 2026.